Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999872722> ?p ?o ?g. }
- W2999872722 endingPage "119031" @default.
- W2999872722 startingPage "119031" @default.
- W2999872722 abstract "This study developed novel ionic liquids (ILs) based on amino acids. We first screened 15 methyl amino acid ester hydrochlorides ([AAC1]Cl) for their skin permeation enhancements using 5-Fluorouracil (5-Fu) and Hydrocortisone (HC) as model drugs. Glycine methyl ester hydrochloride ([GlyC1]Cl), L-proline methyl ester hydrochloride ([L-ProC1]Cl), and L-leucine methyl ester hydrochloride ([L-LeuC1]Cl) were selected, and their ester sites were modified with different carbon chains (C8 and C12). The resulting ILs showed improved permeation to the two drugs. TEWL and CLSM assays revealed the moderation effects of the modified ILs on skin barrier function, whereas L-proline dodecyl ester hydrochloride ([ProC12]Cl) and L-leucine dodecyl ester hydrochloride ([L-LeuC12]Cl) exhibited the strongest activities. Permeation mechanisms were further investigated by ATR-FTIR, solid-NMR, SEM, and TEM analyses. The results suggested that [L-ProC12]Cl and [L-LeuC12]Cl combined the advantages of amino acid esters and IL solvent and could interact with the intercellular lipid domain by the multi-functions of lipid fluidization and lipid extraction, which were observed in a dosage- and time-dependent manner. Additionally, pathological examination suggested that the amino acid ester-based ILs (AAE-ILs) had good biocompatibility. In conclusion, this study has generated novel chemical penetration enhancers (CPEs) based on AAE-ILs and may be potentially utilized in drug transdermal delivery systems (TDDSs)." @default.
- W2999872722 created "2020-01-23" @default.
- W2999872722 creator A5022811200 @default.
- W2999872722 creator A5024812425 @default.
- W2999872722 creator A5039496448 @default.
- W2999872722 creator A5073117733 @default.
- W2999872722 creator A5075716395 @default.
- W2999872722 date "2020-02-01" @default.
- W2999872722 modified "2023-09-26" @default.
- W2999872722 title "Novel skin permeation enhancers based on amino acid ester ionic liquid: Design and permeation mechanism" @default.
- W2999872722 cites W1966424550 @default.
- W2999872722 cites W1973866150 @default.
- W2999872722 cites W1976226925 @default.
- W2999872722 cites W1980637257 @default.
- W2999872722 cites W1981170200 @default.
- W2999872722 cites W1982299367 @default.
- W2999872722 cites W1995912509 @default.
- W2999872722 cites W1997325051 @default.
- W2999872722 cites W1997595167 @default.
- W2999872722 cites W1999806354 @default.
- W2999872722 cites W2003009304 @default.
- W2999872722 cites W2011149424 @default.
- W2999872722 cites W2013712749 @default.
- W2999872722 cites W2017451668 @default.
- W2999872722 cites W2035959269 @default.
- W2999872722 cites W2039460940 @default.
- W2999872722 cites W2040238703 @default.
- W2999872722 cites W2041988114 @default.
- W2999872722 cites W2042036813 @default.
- W2999872722 cites W2042177184 @default.
- W2999872722 cites W2043597900 @default.
- W2999872722 cites W2043798174 @default.
- W2999872722 cites W2045027192 @default.
- W2999872722 cites W2045845920 @default.
- W2999872722 cites W2052319891 @default.
- W2999872722 cites W2053591647 @default.
- W2999872722 cites W2057005647 @default.
- W2999872722 cites W2062905675 @default.
- W2999872722 cites W2067857128 @default.
- W2999872722 cites W2069003171 @default.
- W2999872722 cites W2070969790 @default.
- W2999872722 cites W2074636335 @default.
- W2999872722 cites W2079656087 @default.
- W2999872722 cites W2080102851 @default.
- W2999872722 cites W2080430067 @default.
- W2999872722 cites W2081674091 @default.
- W2999872722 cites W2086141504 @default.
- W2999872722 cites W2090794556 @default.
- W2999872722 cites W2093597250 @default.
- W2999872722 cites W2095526712 @default.
- W2999872722 cites W2100184769 @default.
- W2999872722 cites W2105543218 @default.
- W2999872722 cites W2106311487 @default.
- W2999872722 cites W2140854438 @default.
- W2999872722 cites W2149828333 @default.
- W2999872722 cites W2162853758 @default.
- W2999872722 cites W2275187635 @default.
- W2999872722 cites W2296385665 @default.
- W2999872722 cites W2337603365 @default.
- W2999872722 cites W2536177133 @default.
- W2999872722 cites W2552251644 @default.
- W2999872722 cites W2555232281 @default.
- W2999872722 cites W2555895750 @default.
- W2999872722 cites W2566463473 @default.
- W2999872722 cites W2571239811 @default.
- W2999872722 cites W2580018907 @default.
- W2999872722 cites W2598272637 @default.
- W2999872722 cites W2733932832 @default.
- W2999872722 cites W2765372030 @default.
- W2999872722 cites W2767349429 @default.
- W2999872722 cites W2800013984 @default.
- W2999872722 cites W2884011305 @default.
- W2999872722 cites W2891765718 @default.
- W2999872722 cites W2904905549 @default.
- W2999872722 cites W2909163387 @default.
- W2999872722 cites W2946461942 @default.
- W2999872722 cites W2970337973 @default.
- W2999872722 doi "https://doi.org/10.1016/j.ijpharm.2020.119031" @default.
- W2999872722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31953082" @default.
- W2999872722 hasPublicationYear "2020" @default.
- W2999872722 type Work @default.
- W2999872722 sameAs 2999872722 @default.
- W2999872722 citedByCount "24" @default.
- W2999872722 countsByYear W29998727222020 @default.
- W2999872722 countsByYear W29998727222021 @default.
- W2999872722 countsByYear W29998727222022 @default.
- W2999872722 countsByYear W29998727222023 @default.
- W2999872722 crossrefType "journal-article" @default.
- W2999872722 hasAuthorship W2999872722A5022811200 @default.
- W2999872722 hasAuthorship W2999872722A5024812425 @default.
- W2999872722 hasAuthorship W2999872722A5039496448 @default.
- W2999872722 hasAuthorship W2999872722A5073117733 @default.
- W2999872722 hasAuthorship W2999872722A5075716395 @default.
- W2999872722 hasConcept C13965031 @default.
- W2999872722 hasConcept C154881586 @default.
- W2999872722 hasConcept C161790260 @default.
- W2999872722 hasConcept C178790620 @default.
- W2999872722 hasConcept C185592680 @default.